You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Pretreatment characteristics

From: Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy

   No ENI (109) ENI (103) p
   Frequencies1 (%)  
Plan type Tomotherapy 47 (43%) 47 (46%) 0.081
  IMRT 22 (20%) 28 (28%)  
  Arc 40 (37%) 28 (27%)  
ADT   44 (40%) 98 (95%) <0.001
   Means2 (±SD)  
Age at start of RT   67.5 (±8.5) 67.1 (±7.8) 0.631
Prostate volume (cc)   53.4 (±29.8) 46.2 (±24.3) 0.055
Rectum volume (cc)   92.9 (±53.5) 98.0 (±47.5) 0.467
Bladder volume (cc)   227.7 (±147.4) 206.2 (±164.2) 0.317
  1. 1Person χ2 test. 2Independent samples T-test. Bolded text indicates a statistically significant difference.